Biotech Week articles from April 2004

Biotech Week archives from April 2004

Preoperative treatment with anastrozole reduces need for extensive surgery.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- New data presented at EBCC 2004 indicate that preoperative (neoadjuvant) treatment with anastrozole (Arimidex; AstraZeneca) results in clinically beneficial reductions in tumor volume, extending the...

Pharmaceutical plant workers have no excess mortality.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- A study of pharmaceutical plant employees found no pattern of excess mortality over a 50-year period. "An historical cohort study was conducted of workers at a pharmaceutical manufacturing plant....

ARRY-142886 cleared to advance into human clinical trials.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Array BioPharma, Inc., (ARRY) received notification from the U.S. Food and Drug Administration that its investigational new drug (IND) application is now in effect for ARRY-142886 (AZD6244), allowing...

Positive results reported from Xibrom U.S. phase III trials.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- ISTA Pharmaceuticals, Inc., (ISTA) announced positive, statistically significant results from its initial analysis of the company's U.S. phase III clinical trials of Xibrom (0.1% bromfenac sodium...

Company reports that interleukin-1 gene variants increase risk for early CHD.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Interleukin Genetics, Inc., (ILGN) reported at the American College of Cardiology meeting that pro-inflammatory variants of the interleukin-1 (IL-1) gene cluster are associated with increased risk for...

As obesity skyrockets, center urges action to stem tide of diabetes.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- As reported by the U.S. Centers for Disease Control and Prevention (CDC), an estimated 129.6 million Americans, or 64% of the population, are overweight or obese. As obesity in America has become...

Vaccine preservative has action similar to methylmercury in neurons.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Thimerosal, a preservative in vaccines, has an effect similar to methylmercury on the intracellular Ca[superscript]2+ concentration of rat cerebellar neurons. "The effect of thimerosal, an...

Poll cites consumers' unfamiliarity with nonmedical biotech.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- A majority of people think the general public is unfamiliar with the nonmedical applications arising from the industrial biotechnology sector of the bioindustry, according to a recent Genetic...

Company expands pipeline to include obesity, oncology therapies.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Gilles Gagnon, president and CEO at AEterna Laboratories, Inc., (AEL; AELA), presented the company's extensive product pipeline in oncology, endocrinology, and infectious diseases at the Bio Square 2004...

MQoL-HIV provides accurate quality-of-life measure for Japanese HIV patients.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- The MQoL-HIV test is suitable for measuring quality of life in Japanese HIV patients. Scientists in Japan conducted a study "to evaluate the discriminative properties of the Multidimensional Quality...

Neugene maker reports quarterly loss of $0.10 per share.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- AVI BioPharma, Inc., (AVII) reported financial results for the 3 and 12 months ended December 31, 2003. For the fourth quarter of 2003, AVI reported a net loss of $3.1 million, or $0.10 per share,...

JUVEN added to Ross Products' line.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories' (ABT) Ross Products division has added JUVEN to its line of nutritional products. Based on blend of three key ingredients - arginine, glutamine, and...

$5.9M contract awarded for development of biowarfare technology.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Acacia Research Corporation (CBMX, ACTG) announced that its CombiMatrix Group has received a 2-year contract from the U.S. Department of Defense (DOD) that will provide $5.9 million to further the...

CustomArray launched for DNA expression analysis.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Acacia Research Corporation (CBMX, ACTG) announced the launch of CombiMatrix group's CustomArray DNA Microarray platform, offering researchers the ability to order fully customizable arrays on demand....

Study: Inhaled steroid therapy does not reduce fetal growth.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Inhaled steroid therapy by pregnant women with asthma does not lead to a restriction in fetal growth, according to a new study. In the largest sample to date examining the potential effects that...

Study demonstrates efficacy of automated external defibrillator.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Access CardioSystems announced its Biphasic WaveControl clinical study results at the American College of Cardiology's (ACC) Annual Scientific Session 2004 in New Orleans, Louisiana. The study...

Drug benefits clients beat national drug cost trend.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- A drug trends "scorecard" published by AdvancePCS (ADVP) reveals an impressive tally by health plan sponsors that have aggressively employed pharmacy benefit management tools to slow rising prescription...

Pharmaceutical firm adds VP of clinical, medical affairs.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Adventrx Pharmaceuticals, Inc., (AVRX) announced that Cellia Habita, MD, PhD, has joined its senior management team as VP, Clinical and Medical Affairs. In this role, Habita will be responsible for the...

Three-year laparoscopic instrument agreement signed with Premier.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Aesculap, Inc., announced the award of an agreement with Premier Purchasing Partners for laparoscopic instruments. The Aesculap/Premier contract portfolio now includes laparoscopic instruments,...

RNA, cDNA purification system introduced by genomic services company.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Agencourt Bioscience Corporation, a provider of genomic services and nucleic acid purification products to the life sciences industry, introduced RNAClean, a reagent system for the purification of...

Clinical data on Travatan/Timolol Fixed Combination reported at glaucoma meeting.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Three-month data from several phase III clinical trials on Travatan/Timolol Fixed Combination (TTFC), Alcon's investigational new drug to treat glaucoma, were presented at the American Glaucoma...

Pexelizumab mortality benefit reported from multiple trials.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Alexion Pharmaceuticals, Inc., (ALXN) announced that professor Frans Van de Werf, chairman, Department of Cardiology at the Gasthuisberg Hospital, University of Leuven, Leuven, Belgium, presented...

Savadelis named chief financial officer at pharmaceutical firm.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Alfacell Corporation (ACEL.OB) is pleased to announce that it has appointed Andrew P. Savadelis chief financial officer and senior VP of finance. Savadelis has more than 15 years of experience in...

Response regulator gene devR enhances M. tuberculosis virulence.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- The mycobacterial response regulator gene devR is involved in M. tuberculosis virulence. According to scientists in India, the "devR-devS two-component system of Mycobacterium tuberculosis was...

Cardiac MRI a better predictor of heart attack, death for women.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- The use of non-invasive cardiac magnetic resonance imaging (MRI) appears to be more effective than conventional diagnostic procedures, such as nuclear stress testing and coronary angiography, in the...

Oncology company files shelf registration statement.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc., (ALTH) announced that it has filed a Form S-3 shelf registration with the U.S. Securities and Exchange Commission (SEC). The shelf registration, when declared effective by...

Isis Pharmaceuticals enters RNAi alliance.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Isis Pharmaceuticals, Inc., (ISIS), a company focused on therapeutics targeting RNA, has entered into a strategic alliance with Alnylam Pharmaceuticals, Inc., an RNAi therapeutics company, to develop...

Transdermal patch as effective as intravenous pump for post-op pain control.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Use of a transdermal patch to deliver pain medication was found to be equivalent to medication delivered by an intravenous pump for controlling pain following surgery, according to a new study. ...

Biosciences firm adds members to scientific advisory board.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Ambit Biosciences announced the addition of Tony Hunter, PhD, and Webster Cavenee, PhD, to its scientific advisory board. The new members of the board will advise Ambit as it continues to expand...

Joint function discussed at meeting.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- A new theory of joint function presented in a symposium at the 71st annual meeting of the American Academy of Orthopaedic Surgeons suggests that the development of osteoarthritis in the knee following...

Analysis of NHANES data demonstrates high prevalence of CRP.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- New data findings presented from the 1999-2000 National Health and Nutrition Examination Survey (NHANES) show that elevated C-reactive protein (CRP) is a highly prevalent condition in the United States...

New study demonstrates the benefits of intensive statin therapy.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Results from a new study demonstrate the benefit of initiating intensive cholesterol-lowering therapy within 10 days in people hospitalized with an acute coronary syndrome. The TIMI 22 study...

Study raises questions about chronic diuretics and renal insufficiency.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Data presented from the world's largest heart-failure registry, known as ADHERE (acute decompensated heart failure national registry), raised the question whether chronic diuretics, in widespread use...

Test kit launched to check for residential indoor allergens.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- American Home Laboratories, Inc., (AHL) announced the launch of AllergenREPORT, a home test kit that screens for elevated levels of residential indoor allergens, including dust mite, cockroach, cat, and...

Bioengineering firm expects record revenue growth, income for 2003.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- American Oriental Bioengineering, Inc., (AOBO) announced that it expects record revenue and net income for the full year 2003. AOBO reported net revenues of $1.12 million for the full year 2002,...

NDA filed with FDA for nanoparticle-based Abraxane.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- American Pharmaceutical Partners, Inc., (APP, APPX) and American BioScience, Inc., (ABI) announced that ABI has completed the filing of a New Drug Application (NDA) to the U.S. Food and Drug...

Company helps hospitals, manufacturers respond to new FDA rules.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- AmerisourceBergen Corporation (ABC), a pharmaceutical services company, said it has the broadest array of solutions to help pharmaceutical manufacturers and hospitals respond to the U.S. Food and Drug...

Fully automated high throughput multi-step protein purification system launched.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- The AKTAxpress, launched by Amersham Biosciences, the life sciences business of Amersham (AHM), at Pittcon 2004, Chicago, Illinois, is the first fully integrated protein purification system to deliver...

FDA approves Sensipar for the treatment of secondary hyperparathyroidism.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Amgen, Inc., (AMGN) announced that the U.S. Food and Drug Administration (FDA) approved Sensipar (cinacalcet HCl) following a priority review. Sensipar, an innovative, first-in-class oral...

Leonard Schaeffer joins board of directors.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Amgen, Inc., (AMGN) has appointed Leonard D. Schaeffer to its board of directors. Schaeffer is chairman and CEO of WellPoint Health Networks, Inc., (WLP) the nation's second-largest healthcare...

U.S. orphan drug designation granted for AT1001.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Amicus Therapeutics, Inc., an emerging drug development company focused on the development of a novel therapeutic approach to the treatment of human genetic disorders, with an initial focus on lysosomal...

Total hip arthroplasty in younger patients can yield good survival.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Careful selection of implanted components is necessary to yield good 10- and 15-year results in patients younger than 50 years undergoing total hip arthroplasty, researchers say. "Because the young...

Lactating mammary glands respond to changes in extracellular calcium levels.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Lactating mammary glands respond to changes in extracellular calcium levels According to published research from the United States, "the transfer of calcium from mother to milk during lactation is...

Kinins may help mediate hypotensive effects of taurine.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Kinins appear to help mediate the hypotensive effects of taurine. In a recent study, scientists in India evaluated "the involvement of kinins in the effects of taurine in fructose-fed hypertensive...

Phase I trial for Oxybutynin gel completed.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Antares Pharma, Inc., (ANTR) announced the successful completion of the phase I clinical trial for its oxybutynin topical gel product. The reported product is intended for the treatment of...

Ion pockets on the HCV IRES IIId domain identify targets for inhibition.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Ion pockets on the HCV IRES IIId domain identify targets for inhibition. "The dynamic behavior of the HCV IRES IIId domain is analyzed by means of a 2.6-ns molecular dynamics simulation, starting...

Patents granted for breast marking technology.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Artemis Medical, Inc., announced that it has been issued U.S. Patent 6,699,205, entitled "Biopsy Localization Method and Device" by the U.S. Patent and Trademark office. This patent is the parent...

Company moves to establish new spine distribution network.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- ArthroCare Corp. (ARTC), a multi-business medical device company that develops products based on its patented Coblation technology, announced a new business strategy designed to expand the company's...

Therapeutic boarding schools opened for overweight, obese youths.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Aspen Education Group announced the launch of a new division to address the epidemic of obesity that is afflicting America's children, teens, and young adults. In keeping with Aspen's decade-long...

Autoimmune disease drug maker completes raises $57 million.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Aspreva Pharmaceuticals Corporation announced the completion of a $57 million private equity financing. Sprout Group, one of the oldest and largest U.S. institutional venture capital firms and an...

Research explains why anticancer treatment effective for some, not others.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- A new anticancer agent, gefinitib (Iressa), recently received U.S. Food and Drug Administration (FDA) approval for patients with advanced non-small-cell lung cancer (NSCLC) after a series of clinical...

STELLAR data presented at meeting.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- New data analyses presented from the STELLAR study (statin therapies for elevated lipid levels compared across doses to rosuvastatin) show that AstraZeneca's lipid-lowering statin medication CRESTOR...

Thomas named chief financial officer at reference lab.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Atherotech, Inc., a specialty reference laboratory and developer of the VAP (Vertical Auto Profile) Cholesterol Test, announced the appointment of Ricky W. Thomas as chief financial officer. Thomas...

Agreement signed for Canadian distribution of dermatology products.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc., (ATRX) announced that the company has signed an exclusive marketing agreement with Genpharm for the distribution of specific generic topical dermatology products in Canada. ...

Four-month prostate cancer product approved in Canada.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc., (ATRX) announced that Sanofi-Synthelabo Canada, Atrix's licensee, has received notice of compliance (NOC) from the Therapeutic Products Directorate of Health Canada for Eligard...

Methylene blue virus photoinactivation reviewed.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- The use of MB photoinactivation to remove viral blood product contamination has been reviewed. Scientists in Alabama examined "the current status of the use of methylene blue (MB) photoinactivation...

Rv0577 gene codes for virulence factor.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- The M. tuberculosis Rv0577 gene appears to code for a virulence factor. According to scientists in Spain, "[n]eutral red staining is a cytochemical reaction that has been found to be related to...

Home blood pressure monitoring may be better than office readings.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Home blood pressure monitoring may have better prognostic accuracy than office blood pressure measurements for patients treated for high blood pressure, according to a new study Guillaume Bobrie,...

Complete genome sequence of Saccharopolyspora erythraea reported.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Aventis Bulk S.p.A. has successfully sequenced the whole genome of Saccharopolyspora erythraea. The strain is an industrial overproducer of erythromycin antibiotic. The work was carried out in...

Lovenox effective in non-ST-elevation acute coronary syndromes, study shows.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- The results of a landmark, 10,027-patient study show that Lovenox (enoxaparin sodium injection) is as effective as unfractionated heparin (UFH) in the treatment of high-risk patients with...

Kos announces strategic acquisition of Azmacort franchise.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Kos Pharmaceuticals, Inc., (KOSP) has entered into a product acquisition agreement with Aventis Pharmaceuticals Holdings, Inc., and a supply agreement with Aventis Pharmaceuticals, Inc., to acquire...

Chahine named president, CEO at DNA-based drug company.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Avigen, Inc., (AVGN) announced that Ken Chahine, PhD, J.D., has been promoted to the position of president and CEO. Chahine, previously Avigen's chief operating officer, replaces John Monahan, PhD, who...

Diagnostics company announces second closing of private placement.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Avitar, Inc., (AVR) announced that gross proceeds of $1,000,000 were raised in the second closing of the private placement entered into on September 30, 2003. In the second closing, which was...

Antiretroviral therapy does not prevent HPV-induced genital lesions.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Antiretroviral therapy does not protect HIV+ women against the effects of HPV infection. In a study from Italy, the "effect of antiretroviral therapy on the natural history of human papillomavirus...

Majority of patients taking Levitra report satisfaction.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- According to the results of recent survey data, both patients and physicians are reporting satisfaction with the erectile dysfunction treatment Levitra. Ninety-four percent of the 240 surveyed...

Survey reveals widespread misconceptions about UTI.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- A national survey of 400 women in the U.S. who have experienced uncomplicated urinary tract infections (UTIs) revealed numerous misconceptions about the risk factors and treatment options for this...

Avelox shows clinical success for acute exacerbations of chronic bronchitis.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- A new study shows patients with acute exacerbations of chronic bronchitis (AECB) who took a 5-day course of the antibiotic Avelox (moxifloxacin HCl) achieved a greater clinical cure rate than patients...

Radiation effective for some prostate patients with recurrent cancer.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- For men with prostate cancer who have had their prostate removed and later show signs of cancer recurrence, several factors can help predict response to subsequent radiation therapy, according to a new...

Tumor suppressor genes predict bladder cancer future.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- The presence of two mutated genes in bladder cancer tumors indicates there is a high risk that the cancer will continue grow and spread, says a Baylor College of Medicine (BCM) researcher in a new...

Med-XS Solutions announces surplus medical equipment management contract.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Med-XS Solutions announced a contract with Dallas, Texas-based Baylor Health Care System, to help Baylor manage surplus medical equipment. Under this agreement, effective March 1, 2004, Baylor will...

Brain enzyme thought to regulate appetite.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- A brain enzyme, called AMP-activated protein kinase (AMPK), may help to regulate food intake and body weight, according to new research. The discovery could lead to new approaches for the treatment of...

Supplement maker receives $30M equity commitment.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Bio-One Corporation (BICO) announced that the company has successfully negotiated an agreement for a $30 million equity investment. The share price on the first $15 million will be determined at the...

Gordon named to board of directors at pharmaceuticals firm.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- BioCryst Pharmaceuticals, Inc., (BCRX) announced the appointment of Carl L. Gordon, PhD, CFA, to the company's board of directors. Gordon is a founding General Partner of OrbiMed Advisors, LLC, an...

Biopharmaceutical firm completes $30M series B financing.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- BioRexis Pharmaceutical Corporation announced that it has raised $30 million in a Series B private equity financing led by Prism Venture Partners of Westwood, Massachusetts, and Quaker BioVentures of...

Nanotechnology drug developer reports key achievement.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals (BPA) announced key achievements and financial results for the year ended December 31, 2003. "We are quite pleased with our achievements and progress in the last year....

International Specialty Products acquires biocide maker.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- International Specialty Products, Inc., (ISP) announced that through its subsidiaries, it has acquired the business of Biochema Schwaben. Biochema is a formulator of preservatives and biocides for...

Interpore International, Inc., to be acquired.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Interpore International (BONZ) announced that it has entered into a definitive agreement with Biomet, Inc., (BMET) under which Biomet will acquire all of the outstanding common stock of Interpore for...

Strategic alliance expands company's presence in spinal market.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Biomet, Inc., (BMET) announced that it has entered into a definitive agreement with Interpore International, Inc., (BONZ) under which Biomet will acquire all of the outstanding common stock of Interpore...

Phase II colorectal vaccine trial results updated.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Biomira, Inc., (BIOM, BRA) provided an update of data from the phase II Theratope vaccine colorectal study of 20 patients. A Kaplan-Meier Survival and Time to Disease Progression Curve of the 20...

Wellbutrin maker comments on rating agency outlooks.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Biovail Corporation (BVF, BVF) commented with respect to statements from both Moody's Investors Service and Standard and Poor's Ratings Services. Moody's Investors Service has placed the ratings of...

COPD outcomes study completes patient recruitment.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Boehringer Ingelheim announced completion of patient recruitment - after just 14 months - for the company's large-scale phase IV, 4-year study to evaluate the potential long-term impact of SPIRIVA...

Uniquely tagged NS5B identifies specific inhibitors of HCV polymerase.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Uniquely tagged NS5B identifies specific inhibitors of HCV polymerase. According to published research from Canada, "the interaction of the hepatitis C virus (HCV) RNA-dependent RNA polymerase with...

Pilot study shows symptomatic improvement for men with chronic prostatitis.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Results of a pilot study demonstrate that Flomax (tamsulosin hydrochloride) is superior to placebo in treating the severe urinary dysfunction of chronic prostatitis/chronic pelvic pain syndrome...

Flomax improves chronic prostatitis/chronic pelvic pain syndrome symptoms.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Results of a pilot study demonstrate that Flomax (tamsulosin hydrochloride) is superior to placebo in treating the severe urinary dysfunction of chronic prostatitis/chronic pelvic pain syndrome...